Oral Combination Provides Alternative To IV Chemo For Multiple Myeloma
Univ. of Rochester Leads Trial Of Combination Chemotherapy For Pancreatic Cancer
Micafungin Bests Fluconazole In Phase III Antifungal Trial
Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients
Navelbine+Herceptin: 78% Response In Breast Cancer
Substance From Sea Squirts In Phase II For Breast Cancer
Colorectal Cancer Gene Carriers Seek Screening More Frequently, Study Finds
More Surgical Patients Die When Nurse Caseloads Rise
Neural Stem Cells Track, Treat, Brain Tumors In Mice
Cancer Clinical Trials Approved By NCI Last Month Are Listed
Trending Stories
- Trump backs off the 100% pharma tariffs ultimatum
- Sakaguchi, Ramsdell, Rudensky win Crafoord Prize for discoveries in immune regulation
- Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research
- White House announces “TrumpRx,” a new prescription drug website
- U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs - Pulitzer-winning healthcare reporter Laurie McGinley on her shift to advocacy work with PACR